TREK-1 activators constitute a class of chemicals that act to enhance the function of the TREK-1 potassium channel, a member of the two-pore domain potassium (K2P) channel family. These channels are involved in maintaining the resting membrane potential and cellular excitability in neurons. TREK-1 activators achieve their effects either by directly interacting with the channel and increasing its open probability or by modulating the channel's gating mechanisms. This group of chemicals comprises a diverse set of compounds, including certain fatty acids, endocannabinoids, a neuroprotective agent, a small molecule activator, a nonsteroidal anti-inflammatory drug and a phosphodiesterase 5 inhibitor. Arachidonic acid, oleic acid, and linolenic acid are polyunsaturated fatty acids that directly activate TREK-1 channels. The binding of these fatty acids to TREK-1 increases the channel's open probability, leading to greater potassium conductance and hyperpolarisation of the neuronal membrane. Similarly, endocannabinoids such as anandamide, N-arachidonoyl dopamine, N-arachidonoyl serotonin, and 2-Arachidonoylglycerol interact directly with the TREK-1 channel, enhancing its open probability and thus leading to increased potassium conductance and hyperpolarisation.
Riluzole, a neuroprotective agent, and ML67-33, a small molecule activator, also directly activate the TREK-1 channel, enhancing its conductance and contributing to neuronal membrane hyperpolarisation. BL-1249, a nonsteroidal anti-inflammatory drug (NSAID), and vardenafil, a phosphodiesterase 5 inhibitor, activate TREK-1 channels via distinct mechanisms, but both lead to an increased open probability of the channel and thus increased potassium conductance and neuronal membrane hyperpolarisation. Lastly, palmitoyl ethanolamide, a fatty acid amide, acts directly on TREK-1 to enhance its open probability, leading to increased potassium conductance and hyperpolarisation of the neuronal membrane. In summary, all these chemical activators of TREK-1 work by enhancing the open probability of the channel, thus increasing potassium conductance and leading to neuronal membrane hyperpolarisation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic acid, a polyunsaturated fatty acid, activates TREK-1 channels via direct binding. The binding of arachidonic acid increases the open probability of TREK-1 channels, leading to an increase in potassium conductance and hyperpolarisation of the neuronal membrane. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic acid, a monounsaturated fatty acid, directly activates TREK-1 channels. Like arachidonic acid, oleic acid binding increases the open probability of TREK-1 channels, enhancing potassium conductance and leading to neuronal membrane hyperpolarisation. | ||||||
α-Linolenic Acid | 463-40-1 | sc-205545 sc-205545A | 50 mg 250 mg | $38.00 $115.00 | 2 | |
Linolenic acid, a polyunsaturated fatty acid, activates TREK-1 channels in a manner similar to arachidonic acid and oleic acid. Its binding increases the channel open probability, enhancing potassium conductance and promoting neuronal membrane hyperpolarisation. | ||||||
Riluzole | 1744-22-5 | sc-201081 sc-201081A sc-201081B sc-201081C | 20 mg 100 mg 1 g 25 g | $20.00 $193.00 $213.00 $317.00 | 1 | |
Riluzole, a neuroprotective agent, directly activates TREK-1 channels. The activation of TREK-1 by riluzole enhances potassium conductance and hyperpolarises the neuronal membrane, contributing to its neuroprotective properties. | ||||||
Palmitoylethanolamide | 544-31-0 | sc-202754 sc-202754A sc-202754B sc-202754C sc-202754D | 10 mg 50 mg 500 mg 1 g 10 g | $80.00 $243.00 $2091.00 $3339.00 $16657.00 | ||
Palmitoyl ethanolamide, a fatty acid amide, activates TREK-1 channels. Its direct interaction with the channel enhances its open probability, leading to increased potassium conductance and membrane hyperpolarisation. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a phosphodiesterase 5 inhibitor, enhances the activity of TREK-1 channels. Its action increases the open probability of TREK-1 channels, leading to increased potassium conductance and neuronal membrane hyperpolarisation. | ||||||